Semaglutide is a newer drug, and it is FDA-approved for weight-loss Semaglutide is a much newer injectable drug that mimics an important hunger-regulating hormone in our bodies, called GLP-1
doi:10.1016/j.metabol.2024.156113 26
No substitutions, transfers or redemption for cash unless otherwise noted below
If concomitant use of VYVANSE with other serotonergic drugs or CYP2D6 inhibitors is clinically warranted, initiate VYVANSE with lower doses, monitor patients for the emergence of serotonin syndrome during drug initiation or titration, and inform patients of the increased risk for serotonin syndrome
PlexusDx serves all 50 states, requires no insurance or membership, and HSA/FSA accounts are eligible
Weight-based dosing calculations require knowing your current weight